Literature DB >> 24356061

Vitamin A and carotenoids and the risk of Parkinson's disease: a systematic review and meta-analysis.

Andrea Takeda1, Olga P Nyssen, Asmat Syed, Eugene Jansen, Bas Bueno-de-Mesquita, Valentina Gallo.   

Abstract

BACKGROUND: Vitamin A and carotenoids are involved in signalling pathways regulating gene expression in many organs, including the brain. The dopaminergic system is a target of retinoic acid action in the central nervous system. The aim of this review is to assess the epidemiological evidence on the association between blood levels or dietary intakes of vitamin A and carotenoids and risk of Parkinson's disease (PD).
METHODS: PubMed and ISI Web of Science were searched for relevant papers from 1990 to April 2013. Data reported in epidemiological studies assessing the association between vitamin A and/or carotenoids (α-carotene, β-carotene, β-cryptoxanthin, lutein, lycopene, zeaxanthin and canthaxanthin) and PD were extracted for a narrative synthesis and meta-analysis.
RESULTS: Thirteen papers were included out of a total of 362 potentially relevant; of these, eight contributed to the meta-analysis. No statistically significant pooled estimate between micronutrient and PD was detected. Forest plots suggest possible non-significant inverse pooled estimates of α-carotene and β-carotene and risk of PD. A significant association between lutein intake and PD risk was detected in case-control studies only.
CONCLUSIONS: Data published to date are insufficient for drawing definite conclusions about the epidemiological evidence on the association between blood levels or dietary intakes of vitamin A and carotenoids and the risk of PD. Results should be interpreted particularly cautiously given the limitation of the present meta-analysis and the potential publication bias. Authors are urged to follow more closely the recommendations for reporting epidemiological studies in order to enhance the capacity for synthesising the evidence.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24356061     DOI: 10.1159/000355849

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  22 in total

Review 1.  Carotenoids: biochemistry, pharmacology and treatment.

Authors:  Alireza Milani; Marzieh Basirnejad; Sepideh Shahbazi; Azam Bolhassani
Journal:  Br J Pharmacol       Date:  2016-10-29       Impact factor: 8.739

Review 2.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

Review 3.  An umbrella review of systematic reviews with meta-analysis on the role of vitamins in Parkinson's disease.

Authors:  Sama Rahnemayan; Sasan Ghazanfar Ahari; Reza Rikhtegar; Sevda Riyahifar; Sarvin Sanaie
Journal:  Acta Neurol Belg       Date:  2022-08-03       Impact factor: 2.471

Review 4.  Dietary Antioxidants and Risk of Parkinson's Disease: A Systematic Review and Dose-Response Meta-analysis of Observational Studies.

Authors:  Sepide Talebi; Seyed Mojtaba Ghoreishy; Ahmad Jayedi; Nikolaj Travica; Hamed Mohammadi
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

5.  Dietary β-carotene and vitamin A and risk of Parkinson disease: A protocol for systematic review and meta-analysis.

Authors:  Ling-Yu Wu; Jing-Xin Chen; Gui-Sheng Chen; Hua Gao; Jing-Hong Huo; Yu-Fei Pang; Qing-Han Gao
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

Review 6.  Morphogens and blood-brain barrier function in health and disease.

Authors:  Nienke R Wevers; Helga E de Vries
Journal:  Tissue Barriers       Date:  2015-09-11

7.  Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.

Authors:  Shreesh Ojha; Hayate Javed; Sheikh Azimullah; Salema B Abul Khair; M Emdadul Haque
Journal:  Neurotox Res       Date:  2015-11-25       Impact factor: 3.911

Review 8.  Nutritional habits, risk, and progression of Parkinson disease.

Authors:  Roberto Erro; Francesco Brigo; Stefano Tamburin; Mauro Zamboni; Angelo Antonini; Michele Tinazzi
Journal:  J Neurol       Date:  2017-10-10       Impact factor: 4.849

Review 9.  Linking chronic kidney disease and Parkinson's disease: a literature review.

Authors:  Jesús D Meléndez-Flores; Ingrid Estrada-Bellmann
Journal:  Metab Brain Dis       Date:  2020-09-29       Impact factor: 3.584

10.  Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.

Authors:  Colleen S Limegrover; Raymond Yurko; Nicholas J Izzo; Kelsie M LaBarbera; Courtney Rehak; Gary Look; Gilbert Rishton; Hank Safferstein; Susan M Catalano
Journal:  J Neurosci Res       Date:  2021-01-22       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.